Flowvium

公司比較

並排比較供應鏈位置、機構信號和新聞間隙評分。

VS

市值區間

中型vs巨型

鏈條角色

intermediaryvsleader

間隙評分

N/AvsN/A

IB活動

N/AvsN/A

營收結構比較

MRNA
NVDA
MRN

Moderna, Inc.

MRNA · pharma-biotech

intermediary中型 ($1B+)
完整資料

簡介

Moderna pioneered commercial mRNA technology with its COVID-19 vaccine and is now building a multi-product mRNA platform spanning infectious disease, oncology, and rare genetic disorders. Its RSV vaccine approval and cancer-vaccine pipeline represent the next phase of mRNA's therapeutic potential.

成立時間

2010

員工人數

6,000+

總部

Cambridge, Massachusetts, USA

營收

$8.8B

COVID-19 Vaccines62%
RSV Vaccine20%
Grants & Collaborations10%
Other Pipeline Products8%

新聞缺口信號

此股票代碼沒有新聞缺口數據。

機構信號

此代號沒有13F信號記錄。

關鍵關係

PFE· Pfizer Inc.
competitor
LLY· Eli Lilly and Company
partner
REGN· Regeneron Pharmaceuticals
competitor
NVD

NVIDIA Corporation

NVDA · semiconductors

leader巨型 ($1T+)
完整資料

簡介

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

成立時間

1993

員工人數

32,000+

總部

Santa Clara, California, USA

營收

$130.5B

Data Center78%
Gaming12%
Professional Visualization4%
Automotive & Robotics4%
OEM & Other2%

新聞缺口信號

此股票代碼沒有新聞缺口數據。

機構信號

此代號沒有13F信號記錄。

關鍵關係

TSM· Taiwan Semiconductor Manufacturing Company
supplier
005930.KS· Samsung Electronics
supplier
000660.KS· SK Hynix
supplier
MU· Micron Technology
supplier
MSFT· Microsoft Corporation
customer